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ABSTRACT
ATP‐sensitive potassium [K(ATP)] channels sense intracellular ATP/ADP levels, being essential components of a glucose‐sensing apparatus in various
cells that couples glucosemetabolism, intracellular ATP/ADP levels andmembrane potential. These channels are present in human chondrocytes, but
their subunit composition and functions are unknown. This study aimed at elucidating the subunit composition of K(ATP) channels expressed in
human chondrocytes and determining whether they play a role in regulating the abundance of major glucose transporters, GLUT‐1 and GLUT‐3, and
glucose transport capacity. The results obtained show that human chondrocytes express the pore forming subunits, Kir6.1 and Kir6.2, at the mRNA
and protein levels and the regulatory sulfonylurea receptor (SUR) subunits, SUR2Aand SUR2B, but not SUR1. The expression of these subunitswas no
affected by culture under hyperglycemia‐like conditions. Functional impairment of the channel activity, using a SUR blocker (glibenclamide 10 or
20nM), reduced the protein levels of GLUT‐1 and GLUT‐3 by approximately 30% in normal chondrocytes, while in cells from cartilage with
increasing osteoarthritic (OA) grade no changes were observed. Glucose transport capacity, however, was not affected in normal or OA chondrocytes.
These results show that K(ATP) channel activity regulates the abundance of GLUT‐1 and GLUT‐3, although other mechanisms are involved in
regulating the overall glucose transport capacity of human chondrocytes. Therefore, K(ATP) channels are potential components of a broad glucose
sensing apparatus thatmodulates glucose transporters and allows human chondrocytes to adjust to varying extracellular glucose concentrations. This
function of K(ATP) channels seems to be impaired in OA chondrocytes. J. Cell. Biochem. 114: 1879–1889, 2013.  2013 Wiley Periodicals, Inc.
KEY WORDS: ARTICULAR CARTILAGE; OSTEOARTHRITIS; K(ATP) CHANNEL; GLUCOSE TRANSPORTER; HUMAN CHONDROCYTE; HYPERGLYCEMIA
Glucose serves an important anabolic function in chondrocytes,being required for the synthesis of matrix components. Due to the avascular nature of cartilage, chondrocytes are physiologicallyexposed to low oxygen tensions [Zhou et al., 2004; Grimshaw and
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Mason, 2000; Kay et al., 2011], using glycolysis as the main energy
source [Rajpurohit et al., 1996], even when exposed to normoxia
[Schneider et al., 2007]. The supply of glucose to chondrocytes
depends on diffusion from the synovial ﬂuid [Maroudas, 1970] which
is facilitated by joint motion and ﬂuid ﬂow in the extracellular matrix
(ECM). The synovial ﬂuid glucose concentration is identical to that in
the plasma both in normal conditions and in non‐inﬂammatory and
inﬂammatory types of arthritis, except in septic arthritis where it is
usually signiﬁcantly reduced [Brannan and Jerrard, 2006]. Several
members of the facilitative glucose transporter family—the GLUT/
SLC2A transporters—are expressed in chondrocytes and optimize its
uptake [Mobasheri et al., 2008]. GLUT‐1 is especially important as
both anabolic and catabolic stimuli increase its expression, while
others, like GLUT‐3, which is also highly expressed constitutively,
does not seem to be regulated by those stimuli [Richardson et al., 2003;
Shikhman et al., 2004; Phillips et al., 2005; Mobasheri et al., 2008].
On the other hand, extracellular glucose concentrations both
below and above physiologic levels, have been predicted and shown
to alter the pattern of gene expression [Mobasheri et al., 2002; Rosa
et al., 2011], as well as the availability of GLUT‐1 protein [Rosa
et al., 2009] in chondrocytes. Indeed, glucose deprivation increases
the expression of GLUT‐1, whereas a supra‐physiologic glucose
concentration has the opposite effect, decreasing GLUT‐1 content and
glucose uptake in young/healthy chondrocytes, but has no effect on
those isolated from osteoarthritic (OA) cartilage [Rosa et al., 2009].
Therefore, normal chondrocytes seem to be able to adjust to the
extracellular glucose concentration by modulating the abundance of
GLUT‐1 and the total glucose transport capacity. Nonetheless, this
ability seems to be compromised in OA chondrocytes in vitro, leading
to intracellular glucose accumulation, increased production of
reactive oxygen species [Rosa et al., 2009] and expression of matrix
degrading enzymes [Rosa et al., 2011] when these cells are exposed to
supra‐physiologic glucose concentrations, as those occurring in
diabetes mellitus, metabolic syndrome and other conditions charac-
terized by impaired glucose metabolism. These conditions are
increasingly recognized as independent risk factors for OA develop-
ment and progression [Hart et al., 1995; Sturmer et al., 2001; Del
Rosso et al., 2006; Katz et al., 2010; Velasquez and Katz, 2010;
Berenbaum, 2011; Schett et al., 2013]. OA is the major musculoskele-
tal disorder—or most likely, a set of disorders with distinct etiological
and clinical characteristics [Berenbaum, 2011; Zhuo et al., 2012]—and
a main cause of physical disability [Martel‐Pelletier et al., 2008;
Goldring andMarcu, 2009]. Understanding how human chondrocytes
sense extracellular glucose and intracellular ATP concentrations and
adjust their substrate uptake to match the cell0s needs and whether
such mechanisms remain functional in OA chondrocytes is, thus,
critical to elucidate the mechanisms by which conditions associated
with impaired glucose metabolism contribute to the development
and/or progression of OA.
ATP‐sensitive potassium [K(ATP)] channels are weak inwardly
rectifying potassium channels that act as metabolic sensors in a
number of cell types, coupling metabolic activity to the membrane
potential and to secretory activity, primarily by sensing intracellular
ATP levels [Miki et al., 2002; Minami et al., 2004; Burke et al., 2008;
McTaggart et al., 2010]. In pancreatic b‐cells [Burke et al., 2008] and
in subpopulations of mediobasal hypothalamic neurons [Acosta‐
Martinez and Levine, 2007], for instance, K(ATP) channels have been
identiﬁed as an essential component of a glucose‐sensing mecha-
nism, wherein uptake and metabolism of glucose leads to increased
intracellular ATP/ADP levels, closure of the channels, and increase in
insulin secretion and neuronal excitability, respectively.
Structurally, K(ATP) channels are heteromultimers of four ATP‐
binding cassette (ABC) proteins that form the sulfonylurea receptor
(SUR), surrounding four pore forming potassium channel subunits
(Kir6) [Babenko et al., 1998]. Kir6 and SUR have two isoforms each,
Kir6.1 and Kir6.2 and SUR1 and SUR2, respectively. SUR2 has two
major splice variants, SUR2A and SUR2B [Burke et al., 2008; Hibino
et al., 2010]. ATP binds to the SUR subunits inducing a
conformational change of the Kir6 subunits that results in channel
closure, cessation of Kþ efﬂux and cell membrane depolarization. In
contrast, decreased intracellular ATP availability allows ADP binding
and channel opening with the consequent Kþ efﬂux and hyperpolar-
ization [Babenko et al., 1998; Shi et al., 2005].
The subunit composition of K(ATP) channels determines their
sensitivity to intracellular ATP and to pharmacological modulators,
eliciting the functional diversity of these channels [Babenko
et al., 1998; Inagaki and Seino, 1998; Acosta‐Martinez and
Levine, 2007]. Kir6.1 and Kir6.2 have similar sensitivities to
nucleotides (ATP and ADP), so the differences found are believed to
be due to the SUR subtype existing in each channel or to the
combination of different SUR subunits in the same channel [Shi
et al., 2005; Chan et al., 2008;]. K(ATP) channels involved in coupling
glucose sensing with insulin secretion in pancreatic b‐cells are
composed of Kir6.2 and SUR1 [Nielsen et al., 2007], whereas channels
containing Kir6.2 and SUR2A, found in cardiomyocytes, and channels
composed of Kir6.2 or Kir6.1 and SUR2B, occurring in vascular cells,
regulate the duration of the action potential and vasodilation
[Aguilar‐Bryan and Bryan, 1999; Gribble and Ashcroft, 2000; Burke
et al., 2008; Chan et al., 2008; Hibino et al., 2010].
Information regarding the subunit composition and function of K
(ATP) channels expressed in non‐excitable cells is much scarcer.
Functional K(ATP) channels have been demonstrated in equine
chondrocytes and Kir6.1 was detected in normal and OA human
cartilage [Mobasheri et al., 2007], but their subunit composition and
physiological roles in cartilage are not yet understood, even though
these channels are highly likely to be important for regulation of
cartilage metabolism and sensing ATP levels within the cell [Barrett‐
Jolley et al., 2010; Mobasheri et al., 2012]. We hypothesize that K
(ATP) channels, by responding to ATP levels, may indirectly act as
components of the glucose sensing apparatus in chondrocytes,
generating signals that allow the cell to adjust to varying extracellular
glucose concentrations by regulating the availability of its facilitative
glucose transporters and hence net glucose transport capacity.
Therefore, this work was aimed at (i) elucidating the subunit
composition of K(ATP) channels expressed in human chondrocytes
and (ii) determiningwhether K(ATP) channels play a role in regulating
the abundance of two major glucose transporters in chondrocytes,
GLUT‐1 and GLUT‐3, and the glucose transport capacity of human
chondrocytes exposed to hyperglycemia‐like conditions. Further-
more, these processes were evaluated in chondrocytes isolated from
cartilage samples with different degradation grades to determine
whether they are impaired in OA.
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MATERIALS AND METHODS
CARTILAGE SAMPLES
Human knee cartilage was collected, within 12 h of death, from the
distal femoral condyles of multi‐organ donors (24–70 years old,
mean¼ 49.9, n¼ 20) or with informed consent from patients (60–76
years old, mean¼ 67.7, n¼ 10) undergoing total knee replacement
surgery at the Orthopaedic Department of the University Hospital of
Coimbra (HUC). The Ethics Committee of HUC approved all
procedures. The cartilage samples were divided in three groups
according to the degree of macroscopic damage, using the
classiﬁcation of Outerbridge (1961). Groups 0–1 (n¼ 11, 24–70
years old, mean¼ 41.5), includes cartilage samples with no
macroscopic signs of degradation (score 0) or presenting only a
softened surface (score 1); Groups 2–3 (n¼ 9, 47–70 years old,
mean¼ 60.1) includes ﬁbrillated or ﬁssured cartilage samples
without evident signs of surface erosion (scores 2 and 3); and Group
4 (n¼ 10, 60–76 years old, mean¼ 67.7) comprises severely damaged
cartilage samples, with areas of extensive full thickness erosion that
exposed the subchondral bone, corresponding to advanced OA.
CHONDROCYTE ISOLATION AND CULTURE
Chondrocytes were isolated by enzymatic digestion from non‐pooled
cartilage samples, as described previously [Rosa et al., 2008]. To avoid
dedifferentiation, conﬂuent non‐proliferating monolayer cultures
were established from each cartilage sample, allowed to recover in
Ham F‐12medium containing 5% fetal bovine serum for 24 h, serum‐
starved for at least 6 h and maintained thereafter in serum‐free
culture medium. Serum‐starved chondrocyte cultures were treated
with glibenclamide (Tocris Biosciences, UK) or high glucose as
indicated in Results Section and in legends of ﬁgures and tables.
ASSESSMENT OF CELL VIABILITY
The 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium (MTT, Sig-
maChemical Co., St. Louis,MO) reduction assay [Mosmann, 1983]was
used to evaluate cell viability in order to assess possible cytotoxic
effects of culturing chondrocyte under hyperglycemia‐like conditions.
Chondrocyte cultures treated or notwith high glucose (30mM) for 18 h
were incubated, for 1 h, at 37°C,with a 0.5mg/mlMTT solution inHam
F‐12 medium. The dark blue crystals of formazan produced were
dissolved in acidiﬁed isopropanol, and formazan quantiﬁcation was
performed by measuring the absorbance of the corresponding
solution, using an automatic plate reader (SLT, Austria) set at a test
wavelength of 570 nm and a reference wavelength of 620 nm.
WESTERN BLOTTING
Whole cell extracts were prepared as previously described [Rosa
et al., 2009]. The proteins in the extracts (25mg) and molecular
weight markers (All blue, Precision Plus molecular weight markers,
Bio‐Rad Laboratories Inc., Hercules, CA) were separated by SDS–
PAGE and transferred to PVDF membranes by electroblotting.
Membranes were probed with Rabbit polyclonal antibodies against
human GLUT‐1 and GLUT‐3 (Millipore, Tremecula, CA), mouse
monoclonal anti‐human SUR1 (Abcam, Cambridge, UK), goat
polyclonal anti‐human SUR2A, SUR2B, and Kir6.1 and rabbit
polyclonal anti‐human Kir6.2 (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA) antibodies and then with an alkaline phosphatase‐
conjugated secondary antibody. Immune complexes were detected
using the Enhanced ChemiFluorescence reagent (GE Healthcare, UK)
in a Typhoon FLA 9000 scanner (GE Healthcare). A mouse anti‐
human b‐tubulin monoclonal antibody (Sigma–Aldrich, Co., St.
Louis, MO) was used to detect b‐tubulin as a loading control. The
intensity of the bands was analyzed using ImageQuant™ TL (version
7.0, GE Healthcare). The results were normalized by calculating the
ratio between the intensities of the bands corresponding to the
protein of interest and b‐tubulin.
IMMUNOHISTOCHEMISTRY
Five millimeters of diameter full depth cartilage cores were collected
from the distal femoral condyles of multi‐organ donors, immersed in
OCT embedding compound (TAAB Laboratories, UK) and immediately
frozen at80°C. Cryostat sections, 10 µm thick, were ﬁxed in acetone
at 20°C for 10min and incubated with the primary antibodies
against Kir6.1, Kir6.2, SUR1, SUR2A, and SUR2B mentioned in the
Western blot section. Secondary antibodies used were Alexa ﬂuor
488‐conjugated goat anti‐rabbit, Alexa ﬂuor 488‐conjugated goat
anti‐mouse (Molecular Probes, Eugene, OR), and FITC‐conjugated
rabbit anti‐goat (Serotech Laboratories, Toronto, Canada). Counter-
staining was performed with DAPI (Sigma–Aldrich) to allow nuclear
visualization. Speciﬁcity was assessed by omitting the ﬁrst antibody
(negative control). Images of cartilage sections were acquired in a
confocal laser‐scanning microscope (Zeiss LSM 710, Carl Zeiss Co.,
Germany) using an excitation ﬁlter of 500 nm and an emission ﬁlter
of 520 nm. The acquisition settings were maintained throughout the
imaging workﬂow.
2‐DEOXY‐D‐Glucose Uptake Assay
Glucose transport was determined by measuring the net uptake of a
non‐metabolizable analogue of glucose, 2‐deoxy‐D‐glucose (2‐DG),
as previously described [Rosa et al., 2009]. Brieﬂy, chondrocytes were
pre‐incubated for 18 h with Glibenclamide (10, 20, 100 nM, and
20mM) and then incubated for 30min at 37°C in glucose‐free DMEM
containing 0.5mM 2‐DG and 0.5mCi/ml of [2,6‐3H]‐2‐DG. Cytocha-
lasin B, a glucose transporter inhibitor (10mM), was used to determine
the non‐speciﬁc uptake. For each sample, the non‐speciﬁc uptake
was subtracted from the total uptake, before normalization to the
respective protein concentration.
TOTAL RNA EXTRACTION AND QUANTITATIVE REAL‐TIME RT‐PCR
(QRT‐PCR)
Total RNAwas extracted from chondrocytemonolayers using TRIzol®
Reagent (Invitrogen, Life Technologies, Co., Paisley, UK) and
quantiﬁed using a NanoDrop ND‐1000 spectrophotometer at
260 nm. Purity and integrity of RNA were assessed as the 240/260
and 280/260 ratios. The cDNA was reverse transcribed using the
iScript Select cDNA Synthesis Kit (Bio‐Rad), beginning with 1 µg of
RNA. Speciﬁc sets of primers for GLUT‐1, GLUT‐3, Kir6.1, Kir6.2,
SUR1, SUR2A, SUR2B, and for the housekeeping genes, 18S, GAPDH
and L13 (Table I) were designed using Beacon Designer software
(PREMIER Biosoft International, Palo Alto, CA). PCR reactions were
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performed using 25mg/ml of transcribed cDNA in a ﬁnal volume of
20 µl.
The efﬁciency of the ampliﬁcation reaction for each gene was
calculated using a standard curve of a series of diluted cDNA samples,
and the speciﬁcity of the ampliﬁcation products was assessed by
analyzing the melting curve generated in the process.
Gene expression changes were analyzed using the built‐in iQ5
Optical system software v2, which enables the analysis of the results
with the Pfafﬂ method, a variation of the DDCT method corrected for
gene‐speciﬁc efﬁciencies [Nolan et al., 2006].
The results for each gene of interest were normalized against 18S,
the housekeeping gene found to be the most stable under the
experimental conditions used, as determined with Genex® software
(MultiD Analyses, AB).
STATISTICAL ANALYSIS
Results are presented as mean SEM. Statistical analysis was
performed using GraphPad Prism (version 5.00). SPSS software
(version 17.0) was used to assess the normality (Kolmogorov–
Smirnov test) and homogeneity of variances to determine whether the
conditions required to apply parametric tests were satisﬁed. As in all
cases such conditions were observed, the statistical analysis was
performed using the paired t‐test for comparison of each condition
with its respective control or one‐way ANOVA for multiple
comparisons. Data were considered statistically signiﬁcant at
P< 0.05.
RESULTS
CHARACTERIZATION OF THE SUBUNIT COMPOSITION OF K(ATP)
CHANNELS EXPRESSED IN HUMAN CHONDROCYTES
To determine the subunit composition of K(ATP) channels present
in human chondrocytes, we evaluated the expression of the
different Kir and SUR subunits, both at the protein and mRNA
levels, by Western blot and qRT‐PCR, respectively. The results
obtained show that all the pore‐forming and regulatory subunits
that can compose K(ATP) channels are expressed in human
chondrocytes, although with different intensities and inter‐
individual variability (Fig. 1). Kir6.1, SUR1, SUR2A, and SUR2B
are expressed both at the protein and mRNA levels (Fig. 1). Kir6.2 is
apparently the most abundant of the pore‐forming subunits at the
protein level, but its mRNA is absent or, at least, is expressed at very
low levels, which may simply indicate that this protein has a low
turnover. On the other hand, even though the mRNAs of all the
regulatory SUR subunits were detected in human chondrocytes
(Fig. 1C), SUR2B seems to be expressed at the protein level more
intensely than SUR2A, while SUR1 was only detected at very low
levels (Fig. 1A). Nonetheless, the apparently different intensities of
those subunits may simply be accounted for by limitations of the
Western blot technique and distinct afﬁnities of the antibodies
used. Even though it was not possible to gather a sufﬁcient number
of cartilage samples of each OA grade to allow an adequate
statistical analysis of the expression of each Kir6 and SUR subunit
among the three experimental groups deﬁned, the Western blot
images shown in Figure 1B suggest that OA grade does not affect
the protein levels of each subunit.
IMMUNOFLUORESCENCE STAINING OF K(ATP) CHANNEL SUBUNITS
IN NORMAL HUMAN CARTILAGE
To further conﬁrm the results obtained in isolated chondrocytes
(Fig. 1), the presence of each subunit in full depth normal (grades 0–1)
cartilage samples was assessed by immunoﬂuorescence.
Figure 2 shows the presence of chondrocytes staining positively for
Kir6.1, Kir6.2, SUR2A, and SUR2B scattered throughout the cartilage
sections and in the midst of non‐stained chondrocytes. No cells
staining positively for SUR1 could be detected in any of the cartilage
sections analyzed. Although no quantitative analysis of the
immunoﬂuorescence images was performed, these results are in
agreement with those obtained in cell extracts of isolated
chondrocytes where SUR1 was detected at very low levels by
Western blot, while Kir6.2 and SUR2B seem to be more abundant.
ROLE OF EXPOSURE TO HIGH GLUCOSE ON K(ATP) CHANNEL
SUBUNIT PROTEIN AND MRNA EXPRESSION
To elucidate whether exposure to a hyperglycemia‐like glucose
concentration inﬂuences the subunit composition of K(ATP)
channels, chondrocytes, classiﬁed according to OA grade, were
treated with 30mM glucose for 18 h and the protein and mRNA levels
of each subunit were analyzed by Western blot and qRT‐PCR,
respectively. No differences in MTT reduction capacity were found
between chondrocytes of either OA grade, exposed or not to high
glucose for 18 h (data not shown), thus showing that exposure to high
glucose did not affect chondrocyte viability.
The results presented in Figure 1 show that exposure to high
glucose did not signiﬁcantly affect the protein levels of SUR1, SUR2A,
TABLE I. Oligonucleotide Primer Pairs Used for qRT‐PCR
Gene name Genbank accession number Forward sequence Reverse sequence
GLUT‐1 NM_006516.2 50‐CGT CTT CAT CAT CTT CAC TG ‐30 50‐CTC CTC GGG TGT CTT ATC‐30
GLUT‐3 NM_006931.2 50‐CGG CTT CCT CAT TAC CTT C‐30 50‐GGC ACG ACT TAG ACA TTG G‐30
Kir6.1 NM_000352 50‐CAA CTG CTG TGT CCA GAT‐30 50‐ATA CGA ATG GTG ATG TTG GA‐30
Kir6.2 NM_ 000525 50‐CAT AGG CAT TAG TGT AGT‐30 50‐TTA TAG AAG AGG CAA CTG‐30
SUR 1 NM_000352 50‐CAA CTG CTG TGT CCA GAT‐30 50‐ATA CGA ATG GTG ATG TTG GA‐30
SUR 2A NM_005691 50‐AAG CAT TCG GTC ATT GTA G‐30 50‐GCC ACA TAG TAG GTC TGA‐30
SUR 2B NM_020297 50‐TGG AGA GGA TGT GGA GAA‐30 50‐CTG TAA GAA TGG TGA ATG TGA T‐30
18S rRNA NM_022551 50‐GAA GAT ATG CTC ATG TGG TGT TG‐30 50‐CTT GTA CTG GCG TGG ATT CTG‐30
RPL13A NM_012423 50‐GGA AGA GCA ACC AGT TAC TAT GAG‐30 50‐CAG AGT ATA TGA CCA GGT GGA AAG‐30
GAPDH NM_002046 50‐ACA GTC AGC CGC ATC TTC‐30 50‐GCC CAA TAC GAC CAA ATC C‐30
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Fig. 1. Protein and mRNA levels of K(ATP) channel subunits expressed in human chondrocytes. A: Protein content of each Kir6 and SUR subunit in whole cell extracts from human
chondrocytes exposed to high glucose (HG) (30mM) for 18 h or left untreated (control). The protein content of each subunit was evaluated by Western blotting and normalized to
the respective b‐tubulin band. B: Western blot images representative of the protein content of each Kir6 and SUR subunit expressed in human chondrocytes according to OA grade,
as deﬁned inMaterials andMethods Section. MW,molecular weight proteinmarker. C: mRNA content of each Kir6 and SUR subunit in human chondrocytes exposed to high glucose
(HG) (30mM) for 18 h or left untreated (control). The mRNA content of each subunit was evaluated by qRT‐PCR and normalized to the respective 18S rRNA content.
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SUR2B, Kir6.1, or Kir6.2 relative to chondrocytes maintained in
regular culture medium containing 10mM glucose. However, as
shown in Figure 1C, a small, but statistically signiﬁcant difference
was found in the mRNA level of SUR2A between cells treated with
30mM glucose (0.97 0.19) and control cells maintained in regular
medium (10mM glucose) (1.69 0.25). On the other hand, the mRNA
levels of Kir6.2 were approximately 6.5‐fold higher in cells cultured in
high glucose for 18 h (0.028 0.009) than in those kept in regular
medium (0.004 0.002), although the absolute levels in either
condition were very low.
REGULATION OF GLUT‐1 AND GLUT‐3 PROTEIN LEVELS BY THE K
(ATP) CHANNEL BLOCKER, GLIBENCLAMIDE
To determine whether the activity of K(ATP) channels is
involved in the regulation of glucose transporters in human
chondrocytes, the cells were treated for 18 h with glibenclamide, a
widely used SUR inhibitor that blocks K(ATP) channels
[Burke et al., 2008], in concentrations ranging from 10 nM to
20mM.
Data presented on Table II show that there are no signiﬁcant
differences in the basal protein levels of GLUT‐1 and GLUT3 among
Fig. 2. In situ immunoﬂuorescence staining of K(ATP) channel subunits in normal (OA grades 0–1) human cartilage. Each section was stained with an antibody speciﬁc for the
subunit (green) identiﬁed in the upper right corner of the representative image and counterstained with DAPI (blue) to allow visualization of nuclei. Negative controls (column on
the right) were obtained by omitting the primary antibody for each subunit. Cartilage sections were viewed and images captured at 100 and 400 (insets) magniﬁcations.
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the three groups deﬁned according to the macroscopic OA grade, as
deﬁned in Materials and Methods Section.
GLUT‐1 protein levels were signiﬁcantly decreased by treatment of
grades 0–1 chondrocytes with glibenclamide 10 nM (71.24 6.59%,
P¼ 0.0009, n¼ 7) and 20 nM (76.55 9.47%, P¼ 0.029, n¼ 7),
whereas only 10 nM was effective in decreasing GLUT‐1 protein
levels in chondrocytes of OA grades 2–3 (82.16 4.27, P¼ 0.0024,
n¼ 7), and 4 (76.3 8.0, P¼ 0.025, n¼ 7) (Fig. 3A).
Figure 3B represents the results obtained for GLUT 3. It shows that
a signiﬁcant decrease of GLUT‐3 occurs only in chondrocytes from
groups with OA grades 0–1 and 2–3 treated with 10 nM glibenclamide
(64.17 5.89, P¼ 0.0038; n¼ 3 and 79.77 7.38, P¼ 0.0265; n¼ 5,
respectively), while no signiﬁcant differences were found in OA grade
4 chondrocytes with any of the glibenclamide concentrations tested.
Regardless of the OA grade, glibenclamide concentrations above
20 nM had no effect either on GLUT‐1 or ‐3 protein content, although
for each OA grade the variability between chondrocytes isolated from
different cartilage samples was higher than observed by treatment
with 10 nM glibenclamide.
ROLE OF GLIBENCLAMIDE IN REGULATING GLUT‐1 AND GLUT‐3
MRNA LEVELS IN OA GRADES 0–1 CHONDROCYTES
To determine whether the decrease in the protein levels of GLUT‐1
and GLUT‐3 was due to glibenclamide effects at the transcriptional
level, we analyzed the mRNA levels of both glucose transporters by
qRT‐PCR. Figure 3C shows that there were no statistically signiﬁcant
differences in the mRNA levels of either glucose transporter in
glibenclamide‐treated groups compared to the control group at any
treatment period considered.
ROLE OF GLIBENCLAMIDE IN REGULATING CELLULAR GLUCOSE
TRANSPORT CAPACITY
To determine whether the effects of glibenclamide on GLUT‐1 and ‐3
protein levels had functional consequences in terms of glucose
transport capacity by chondrocytes of various OA grades, the uptake
of [3H]2‐DG was measured after treatment with glibenclamide for
18 h. The results obtained (Table III) show no signiﬁcant differences in
2‐DG uptake by cells treated with any of the glibenclamide
concentrations tested, compared with the corresponding control
untreated chondrocytes of the same OA grade.
DISCUSSION AND CONCLUSIONS
Although the presence of Kir6.1 in human and equine chondrocytes
has already been demonstrated [Mobasheri et al., 2007], this study
represents the ﬁrst comprehensive analysis of Kir6.x and SUR
subunits expressed in human articular chondrocytes, both at the
protein and mRNA levels. The results obtained (Figs. 1 and 2) suggest
that Kir6.2 and SUR2B are major K(ATP) channel subunits expressed
in human chondrocytes, while Kir6.1 and SUR2A are likely present at
much lower levels and SUR1 is barely detectable or even undetectable.
How the various Kir and SUR subunits expressed in human
chondrocytes assemble to form functional K(ATP) channels is beyond
the scope of this study and was not investigated. Nonetheless, it is
possible that K(ATP) channels containing more than one SUR subtype
co‐exist with others containing only one SUR isoform. The relative
abundance of each channel type would depend on the expression
level of each subunit, as observed in other cells [Chan et al., 2008;
Wheeler et al., 2008]. Since Kir 6.2 and SUR2B seem to be more
abundant than the other Kir6 and SUR subunits, it seems likely that K
(ATP) channels containing these subunits, namely octamers
composed of Kir6.2 and SUR2B, predominate in human articular
chondrocytes, although all other possible combinations of Kir6 and
SUR subunits can also be present. Even though the scarcity of human
cartilage samples did not allow us to determine the inﬂuence of the
OA grade on the subunit composition of K(ATP) channels in human
chondrocytes, the results presented in Figure 1 suggest that none of
the Kir6 or SUR subunits is affected at the protein level.
The composition of those channels, at least at the protein level, was
not signiﬁcantly affected by culture under a supra‐physiologic
glucose concentration (30mM), unlike demonstrated at the mRNA
level in other cells, namely mediobasal hypothalamic neurons
[Acosta‐Martinez and Levine, 2007] and pancreatic b‐cells [Moritz
et al., 2001].
The nucleotide binding afﬁnity of SUR2B is much higher than that
of SUR2A, but lower than that of SUR1, although its channel gating
activity is similar to that of SUR1 [Matsuo et al., 2000]. Therefore,
SUR2B‐containing K(ATP) channels are functionally very similar to
those that contain SUR1, namely those expressed in pancreatic b‐
cells [Burke et al., 2008] and in mediobasal hypothalamic neurons
[Acosta‐Martinez and Levine, 2007] that readily bindATP in response
to augmented glucose availability. To test the hypothesis that K(ATP)
channels expressed in human chondrocytes behave similarly, we
attempted to measure changes in membrane potential induced by
culture under a supra‐physiologic glucose concentration (30mM)
which is in the range of plasma glucose concentrations found in
diabetic patients. For this, we loaded the cells with the potential‐
sensitive ﬂuorescence dye, bis(1,3‐dibutylbarbituric acid)trimethine
oxonol [DiBAC 4 (3)] that becomes ﬂuorescent upon depolarization.
Unfortunately, we were unable to detect any changes using
ﬂuorescence spectroscopy, probably because changes in membrane
potential occur in a very dynamic and fast manner. Possibly, in vivo
ﬂuorescence imaging may be required to detect such fast and
TABLE II. Basal Protein Levels of GLUTs‐1 and ‐3 in Human Chondrocytes According to OA Grade
0–1 2–3 4
P‐value NOA grade Mean SEM Mean SEM Mean SEM
GLUT‐1 0.58 0.097 0.70 0.29 0.66 0.21 0.919 6
GLUT‐3 1.85 0.58 1.75 0.14 1.49 0.34 0.766 5
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Fig. 3. Regulation of total GLUT‐1 and GLUT‐3 protein content by glibenclamide in chondrocytes from different OA grades. A: Relative GLUT‐1 protein levels normalized to the
respective b‐tubulin band, in whole cell extracts from human chondrocytes of OA grades 0–1 (n¼ 7), 2–3 (n¼ 7), and 4 (n¼ 6) treated with the indicated concentrations of
glibenclamide for 18 h. B: Relative GLUT‐3 protein levels normalized to the respective b‐tubulin band, in whole cell extracts from human chondrocytes of OA grades 0–1 (n¼ 3), 2–
3 (n¼ 5), and 4 (n¼ 6) treated with the indicated concentrations of glibenclamide for 18 h. Results are expressed in percentage relative to control untreated cells of the same OA
grade P< 0.005; P< 0.01; P< 0.05 relative to the respective control cells. MW,molecular weight proteinmarker. C: GLUT‐1 and ‐3mRNA levels in chondrocytes grades 0–1
treated with 10 nM glibenclamide for the time periods indicated, relative to untreated chondrocytes of the same OA grade.
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transient changes. Therefore, we were unable to directly demonstrate
whether glucose availability affects the chondrocyte membrane
potential.
To further test the hypothesis that K(ATP) channels function as
metabolic sensors in human chondrocytes playing a role in the
modulation of glucose transport capacity, we used glibenclamide, a
widely used SUR inhibitor, to block these channels and measured the
whole cell content of major glucose transporters, GLUT‐1 and GLUT‐
3. Glibenclamide displays differential selectivity towards distinct SUR
subunits, beingmoderately selective for SUR1 [Burke et al., 2008]. The
sensitivity of equine chondrocytes to glibenclamide is lower than that
found in cells expressing SUR1 and in the same range of that
presented by cells in which K(ATP) channels contain SUR2B
[Mobasheri et al., 2007] which further suggests that K(ATP) channels
containing this subunit are relevant in human chondrocytes.
Nevertheless, as K(ATP) channels composed of other subunits may
also exist in human chondrocytes, we used glibenclamide concen-
trations ranging from 10 nM to 20mM in order to cover the whole
range of channel sensitivities to this SUR inhibitor. Interestingly, only
the lowest concentration was effective in reducing GLUT‐1 protein
content in chondrocytes from all OA grades, whereas 20 nM was
effective only in grades 0–1 OA chondrocytes (Fig. 3A). GLUT‐3
content, however, was only reduced by treatment of grades 0–1 and
2–3, but not grade 4 OA chondrocytes with glibenclamide 10 nM
(Fig. 3B). These results indicate that closing K(ATP) channels, at least
partially, is sufﬁcient to reduce the cell protein content of two major
glucose transporters, GLUT‐1 and GLUT‐3, without affecting their
mRNA levels, in normal human chondrocytes, in a way similar to the
reduction induced by exposure to 30mM glucose [Rosa et al., 2009].
The inability of OA chondrocytes to downregulate the protein
levels of GLUT‐1 and GLUT‐3 in response to glibenclamide (Fig. 3),
mimicking their inability to adjust to high extracellular glucose
concentrations [Rosa et al., 2009], further indicates that either K(ATP)
channels are functionally defective or some other downstream
component or process is impaired in OA chondrocytes. Nonetheless,
the possibility that ATP production may simultaneously be impaired
in advanced OA chondrocytes cannot be excluded.
Another intriguing question arises from the observation that the
response to glibenclamide in terms of GLUT‐1 and GLUT‐3 protein
content, occurred only with the lowest glibenclamide concentrations
tested. In equine chondrocytes, similar glibenclamide concentrations
(10–20 nM) elicited a partial reduction in current amplitude, while
much higher concentrations in the range of 100–300 nM were
required to completely block K(ATP) channel activity [Mobasheri
et al., 2007]. Therefore, it is possible that different ranges of channel
activity elicit distinct changes in membrane potential that operate
diverse signaling pathways and cell responses. This is further
supported by the observation that K(ATP) channels with distinct
subunit compositions and therefore with different glibenclamide and
nucleotide sensitivities, may coexist in human chondrocytes (Figs. 1
and 2).
Nonetheless, glibenclamide‐induced changes in the total protein
content of GLUT‐1 and GLUT‐3 were not accompanied by
corresponding decreases in glucose transport capacity by chondro-
cytes of any OA grade (Table III). This suggests that even though K
(ATP) channel activity regulates the availability of GLUT‐1 and
GLUT‐3, other mechanisms are involved in the regulation of the
overall glucose transport capacity of human chondrocytes. On one
hand, other glucose transporters known to be expressed in
chondrocytes [Mobasheri et al., 2008] may not be regulated by K
(ATP) channels and compensate for changes in GLUT‐1 and ‐3. On the
other hand, GLUT‐1 has been shown to exist in a dynamic equilibrium
involving the plasma membrane, intracellular storage in the trans
Golgi network and lysosomal degradation [Ortiz et al., 1992]. Our
previous study indicated that high glucose‐induced GLUT‐1 down-
regulation involved lysosomal degradation [Rosa et al., 2009]. Thus, it
is possible that K(ATP) channel activity affects total GLUT‐1 and
possibly GLUT‐3 protein content by increasing lysosomal degrada-
tion of intracellular stores, in agreement with studies in other cells
suggesting that GLUT‐1 degradation and functional membrane
expression may be regulated through independent pathways [Ortiz
et al., 1992].
In summary, this study contributes to elucidate the subunit
composition of K(ATP) channels expressed in human chondrocytes
and establishes a role for these channels as components of the glucose
sensing apparatus in these cells by demonstrating that their activity
inﬂuences the abundance of two major glucose transporters, GLUT‐1
and GLUT‐3. Nonetheless, since glucose transport was not similarly
affected, additional mechanisms must be involved in the adaptation
of human chondrocytes to high extracellular glucose concentrations.
Moreover, this study also shows that chondrocytes isolated from
cartilage of increasing OA grade are less responsive to changes in K
(ATP) channel activity, which may contribute to the inability of OA
chondrocytes to downregulate glucose transporters and avoid the
deleterious effects of high extracellular glucose concentrations that
we have previously observed [Rosa et al., 2009, 2011]. Taken together,
the results presented highlight the importance of K(ATP) channels as
metabolic sensors and potential components of a broad glucose
sensing apparatus that allows human chondrocytes to adjust to
varying extracellular glucose concentrations.
TABLE III. Relative 2‐DG Uptake (% of Untreated Cells)
Glibenclamide (nM)
OA grades 0–1 OA grades 2–3 OA grade 4
Mean SED P‐value N Mean SED P‐value N Mean SED P‐value N
10 92.63 9.79 0.4962 6 106.9 5.98 0.2979 5 94.03 3.14 0.2466 3
20 97.92 1.53 0.2347 6 108.6 8.73 0.3777 4 100.7 4.53 0.8422 3
100 93.95 5.36 0.3322 6 102.2 8.03 0.7749 5 87.33 5.37 0.1629 3
20,000 100.6 3.24 0.8203 6 113.7 8.10 0.1785 4 91.41 8.36 0.4120 3
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